Travere Therapeutics Inc (TVTX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $29.72
• Market Cap: $2.63B
• EPS: $-1.03
• 52-Week High: $42.13
• 52-Week Low: $12.91

Market Sentiment

Travere Therapeutics Inc currently has a Bullish sentiment score of 0.39.

About Travere Therapeutics Inc

Travere Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering, developing, and commercializing innovative therapies for patients with rare diseases. Headquartered in San Diego, California, Travere leverages a robust pipeline aimed at addressing significant unmet medical needs, particularly in the fields of metabolic and genetic disorders. The company's commitment to transforming the lives of patients is underscored by its strategic partnerships and development programs de...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Travere Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does TVTX pay dividends?

Travere Therapeutics Inc (TVTX) does not currently pay a regular dividend.

What is TVTX's market cap?

Travere Therapeutics Inc (TVTX) has a market capitalization of $2.63B with a current stock price of $29.72.